Display options
Cite
Marini A, Vogrig A, Bax F, et al. Reply to "Guillain‑Barré syndrome in the COVID‑19 era another occasional cluster?": Insights from two distinct clusters of Guillain-Barré syndrome detected in Europe in the COVID-19 era. J Neurol. 2020;268(4):1201-1202doi: 10.1007/s00415-020-10006-2.
Marini, A., Vogrig, A., Bax, F., Pellitteri, G., Surcinelli, A., Valente, M., & Gigli, G. L. (2021). Reply to "Guillain‑Barré syndrome in the COVID‑19 era another occasional cluster?": Insights from two distinct clusters of Guillain-Barré syndrome detected in Europe in the COVID-19 era. Journal of neurology, 268(4), 1201-1202. https://doi.org/10.1007/s00415-020-10006-2
Marini, Alessandro, et al. "Reply to "Guillain‑Barré syndrome in the COVID‑19 era another occasional cluster?": Insights from two distinct clusters of Guillain-Barré syndrome detected in Europe in the COVID-19 era." Journal of neurology vol. 268,4 (2021): 1201-1202. doi: https://doi.org/10.1007/s00415-020-10006-2
Marini A, Vogrig A, Bax F, Pellitteri G, Surcinelli A, Valente M, Gigli GL. Reply to "Guillain‑Barré syndrome in the COVID‑19 era another occasional cluster?": Insights from two distinct clusters of Guillain-Barré syndrome detected in Europe in the COVID-19 era. J Neurol. 2021 Apr;268(4):1201-1202. doi: 10.1007/s00415-020-10006-2. Epub 2020 Aug 04. PMID: 32749602; PMCID: PMC7400752.
Copy Download .nbib Format: NLM
Share it on

J Neurol. 2021 Apr;268(4):1201-1202. doi: 10.1007/s00415-020-10006-2. Epub 2020 Aug 04.

Reply to "Guillain‑Barré syndrome in the COVID‑19 era another occasional cluster?": Insights from two distinct clusters of Guillain-Barré syndrome detected in Europe in the COVID-19 era.

Journal of neurology

Alessandro Marini, Alberto Vogrig, Francesco Bax, Gaia Pellitteri, Andrea Surcinelli, Mariarosaria Valente, Gian Luigi Gigli

Affiliations

  1. Neurology Unit, Department of Medicine (DAME), University of Udine, Piazzale Santa Maria della Misericordia 15, 33100, Udine, Italy. [email protected].
  2. Clinical Neurology Unit, Misericordia University Hospital, Santa Maria della Misericordia University Hospital, Udine, Italy.
  3. Neurology Unit, Department of Medicine (DAME), University of Udine, Piazzale Santa Maria della Misericordia 15, 33100, Udine, Italy.
  4. DMIF, University of Udine, Udine, Italy.

PMID: 32749602 PMCID: PMC7400752 DOI: 10.1007/s00415-020-10006-2

[No abstract available.]

References

  1. Gigli GL, Bax F, Marini A et al (2020) Guillain-Barré syndrome in the COVID-19 era: just an occasional cluster? J Neurol. https://doi.org/10.1007/s00415-020-09911-3 - PubMed
  2. Tatu L, Nono S, Gracio S, Kocer S (2020) Guillain-Barré syndrome in the COVID-19 era another occasional cluster? J Neurol (Ahead of print) - PubMed
  3. Coen M, Jeanson G, Culebras Almeida LA et al (2020) Guillain-Barré syndrome as a complication of SARS-CoV-2 infection. Brain Behav Immun. https://doi.org/10.1016/j.bbi.2020.04.074 - PubMed
  4. Lascano AM, Epiney J-B, Coen M, et al SARS-CoV-2 and Guillain-Barré syndrome: AIDP variant with favorable outcome. Eur J Neurol. https://doi.org/10.1111/ene.14368 - PubMed
  5. Riva N, Russo T, Falzone YM et al (2020) Post-infectious Guillain-Barré syndrome related to SARS-CoV-2 infection: a case report. J Neurol. https://doi.org/10.1007/s00415-020-09907-z - PubMed
  6. Toscano G, Palmerini F, Ravaglia S et al (2020) Guillain–Barré Syndrome associated with SARS-CoV-2. N Engl J Med. https://doi.org/10.1056/NEJMc2009191 - PubMed
  7. Tan Y-J, Goh P-Y, Fielding BC et al (2004) Profiles of antibody responses against severe acute respiratory syndrome coronavirus recombinant proteins and their potential use as diagnostic markers. Clin Diagn Lab Immunol 11:362–371. https://doi.org/10.1128/CDLI.11.2.362-371.2004 - PubMed
  8. Meyer B, Drosten C, Müller MA (2014) Serological assays for emerging coronaviruses: challenges and pitfalls. Virus Res 194:175–183. https://doi.org/10.1016/j.virusres.2014.03.018 - PubMed
  9. Long Q-X, Liu B-Z, Deng H-J et al (2020) Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat Med. https://doi.org/10.1038/s41591-020-0897-1 - PubMed
  10. Wu F, Wang A, Liu M et al (2020) Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications. medRxiv. https://doi.org/10.1101/2020.03.30.20047365 - PubMed
  11. Wu L-P, Wang N-C, Chang Y-H et al (2007) Duration of antibody responses after severe acute respiratory syndrome. Emerg Infect Dis 13:1562–1564. https://doi.org/10.3201/eid1310.070576 - PubMed
  12. Neher RA, Dyrdak R, Druelle V et al (2020) Potential impact of seasonal forcing on a SARS-CoV-2 pandemic. medRxiv. https://doi.org/10.1101/2020.02.13.20022806 - PubMed

MeSH terms

Publication Types